In exploratory analysis, patients who were able to resume immunotherapy demonstrated a numerically higher 12‐month survival rate compared to those who were not, though this difference did not reach statistical significance.
← all excerpts
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies.
1
—
—